COURTNEY MCCONNELL: Open Payments
NPI 1497476048 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,588 in 204 payments from 26 companies in 2025. Trend: 2023 $0 · 2024 $3,356 · 2025 $5,588
Food & beverage: $5,322Education: $170Consulting: $95
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 29 | $941 |
| AstraZeneca Pharmaceuticals LP | 23 | $726 |
| GENZYME CORPORATION | 15 | $533 |
| Pharming Healthcare, Inc. | 11 | $433 |
| GlaxoSmithKline, LLC. | 20 | $402 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $400 |
| LEO Pharma Inc. | 6 | $294 |
| ARS Pharmaceuticals Operations, Inc. | 8 | $259 |
| Novartis Pharmaceuticals Corporation | 8 | $253 |
| ABBVIE INC. | 6 | $211 |
Products named: DUPIXENT, RUCONEST, FASENRA, NEFFY, ANZUPGO, AIRSUPRA, NUCALA, TEZSPIRE.
Industry payments across NV — which companies pay providers there.
